BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance
Proceedings of the National Academy of Sciences · 17.03.2026 · 123 (11)
DOI: 10.1073/pnas.2530443123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 11.03.2026. Verfasst von Oliver W Chung und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710. Hauptthemen laut MEDLINE: DNA Ligase ATP, BRCA1 Protein, Drug Resistance, Neoplasm, DNA, Circular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Extrachromosomal circular DNA (ecDNA) is frequently generated within the nucleus, contributing to genome dynamics and heterogeneity, thereby promoting cancer cell evolution and adaptation. However, the mechanisms underlying ecDNA biogenesis remain poorly understood. Here, using genome-wide CRISPR screening in human cells, we identified the BRCA1-A and the LIG4 complexes as key drivers of ecDNA production. Following DNA segmentation, the upstream BRCA1-A complex protects DNA ends from excessive resection, promoting end-joining for circularization. Conversely, the MRN complex, which mediates end resection and thus antagonizes the BRCA1-A complex, suppresses ecDNA formation. Downstream, LIG4 conservatively mediates ecDNA production by joining the free ends of the DNA fragments. Furthermore, ecDNA from patient tumors harbors junction sites with a LIG4 signature. Notably, disruption of either LIG4 or the BRCA1-A complex in cancer cells impairs ecDNA-mediated adaptation, hindering the development of resistance to both chemotherapy and targeted therapies. Together, our study reveals the roles of the LIG4 and BRCA1-A complexes in ecDNA biogenesis, and uncovers therapeutic targets to block ecDNA-mediated adaptation for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710.
- The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC 27710.
ORCID-Profile: Ling Wang, Fu Yang, Lauren Schier, Melissa Aldana, Christian Cerda-Smith, Haley M Hutchinson, Kris C Wood, Mustafa Khasraw, Dale A Ramsden, Zz Zhao Zhang
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Chung, O. W., Yao, S., Wang, L., Yang, F., Schier, L., Aldana, M., Cerda-Smith, C., Hutchinson, H. M., Wood, K. C., Su, W., Khasraw, M., Zou, L., Ramsden, D. A., & Zhang, Z. Z. (2026). BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance. Proceedings of the National Academy of Sciences, 123(11). https://doi.org/10.1073/pnas.2530443123
Vancouver
Chung OW, Yao S, Wang L, Yang F, Schier L, Aldana M, et al. BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance. Proceedings of the National Academy of Sciences. 2026;123(11). doi:10.1073/pnas.2530443123
BibTeX
@article{Chung2026,
author = {Chung, Oliver W and Yao, Shun and Wang, Ling and Yang, Fu and Schier, Lauren and Aldana, Melissa and Cerda-Smith, Christian and Hutchinson, Haley M and Wood, Kris C and Su, Weijia and Khasraw, Mustafa and Zou, Lee and Ramsden, Dale A and Zhang, Zz Zhao},
title = {BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {11},
doi = {10.1073/pnas.2530443123}
}
EUVIMED